What question did this study set out to answer?

This research aims to identify clinical characteristics and prognostic factors of ICI-related pneumonitis while assessing the feasibility of continuing ICI therapy after pneumonitis.

March 28, 2026Open Access

Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitis

Puntos clave

This research aims to identify clinical characteristics and prognostic factors of ICI-related pneumonitis while assessing the feasibility of continuing ICI therapy after pneumonitis.
Analyzed characteristics of patients with ICI-related pneumonitis across various malignancies.
Evaluated the percentage of patients who continued ICI therapy after experiencing pneumonitis.
Assessed the role of systematic radiological surveillance and severity-based treatment in managing pneumonitis.
Approximately 20% of patients continued ICI therapy after experiencing pneumonitis.
Management strategies based on severity may improve patient outcomes in ICI therapy.
Consistent radiological follow-up is suggested as beneficial for these patients.

Resumen

The similar characteristics of ICI-pneumonitis across malignancies support the generalizability of management strategies. Approximately one-fifth of patients successfully continued ICI therapy after pneumonitis. Systematic radiological surveillance and appropriate severity-based treatment may help optimize outcomes in patients receiving ICI therapy.

Me gusta

Guardar

Ver artículo completo